Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Jessica C. Hochberg, MD, Stanton Goldman, MD, Matthew J. Barth, MD, Qiuhu Shi, PhD, Liana Klejmont, Pharm D, Lauren Harrison, RN, MSN, Jackie Basso, Yaya Chu, PhD, Humayun Islam, Perry Gerard, MD MBA, FACR, Javier Oesterheld, MD, Kenneth Matthew Heym, MD, Ivan I. Kirov, MD, Richard A. Drachtman, MD, Paul Harker-Murray, MD PhD, Sherrie L. Perkins, MD PhD, Rodney R. Miles, MD PhD, Bruce Shiramizu, MD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139464

Published: 2020

Journal Articles

Utilizing Medical Students As Patient Mentors: An Intervention to Improve Transition Readiness in Young Adults with Sickle Cell Disease

Adrienne Viola, PhD MPH, Richard A. Drachtman, MD, Amanda Kaveney, MD, Ashwin Sridharan, MD, Beth Savage, MSN, ANP, Jerlym S. Porter, PhD MPH, Katie Devine, PhD MPH

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-142021

Published: 2020

Journal Articles

Changes in Serum TARC Predict PET Response Among Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma Treated with Brentuximab Vedotin and Gemcitabine: A Report from the Children's Oncology Group

Peter D Cole, MD, Menachem Spira, MD, Kathleen M McCarten, MD, Terzah M Horton, MD, Quinglin Pei, PhD, Monika Metzger, Richard A Drachtman, MD, Kara M. Kelly, MD

Blood (2017) 130 (Supplement 1): 2798.

https://doi.org/10.1182/blood.V130.Suppl_1.2798.2798

Published: 2017

Journal Articles

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Lynda M. Vrooman, MD, Ivan I. Kirov, MD, Zoann E. Dreyer, MD, Michael Kelly, MD, PhD, Nobuko Hijiya, MD, Patrick Brown, MD, Richard A. Drachtman, MD, Yoav H Messinger, MD, A. Kim Ritchey, MD, Gregory A. Hale, MD, Kelly Maloney, MD, Paul V. Plourde, MD, Lewis B. Silverman, MD

Blood (2013) 122 (21): 3904.

https://doi.org/10.1182/blood.V122.21.3904.3904

Published: 2013

Journal Articles

Novel Homozygous VHL Mutation in Exon 2 (413C>T:P138L) Is Associated with Congenital Polycythemia, Elevated Level of RUNX1/AML1 Transcript, but Not with the Cancer.

Lucie Piterkova, PhD, Felipe R Lorenzo V, M.D., PhD., Hari Vankalayapati, MPharm., PhD., Richard A. Drachtman, MD, Josef T. Prchal, MD

Blood (2012) 120 (21): 2081.

https://doi.org/10.1182/blood.V120.21.2081.2081

Published: 2012

Journal Articles

AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.

Peter D. Cole, MD, Tanya M. Trippett, MD, Richard A. Drachtman, MD, Pedro de Alarcon, MD, Lu Chen, Cindy L. Schwartz, MD

Blood (2007) 110 (11): 2318.

https://doi.org/10.1182/blood.V110.11.2318.2318

Published: 2007

Journal Articles

Phase IIB Trial of Aminopterin in Multiagent Therapy for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) at High Risk of Relapse.

Peter D. Cole, MD, Richard A. Drachtman, MD, Angela K. Smith, Margaret Masterson, MD, John Glod, Md, PhD, Barton A. Kamen, MD, PhD

Blood (2006) 108 (11): 1860.

https://doi.org/10.1182/blood.V108.11.1860.1860

Published: 2006

Journal Articles

Aminopterin Can Replace Methotrexate for Children with Newly Diagnosed Acute Lymphoblastic Leukemia without Excessive Toxicity.

Peter D. Cole, MD, Richard A. Drachtman, MD, Margaret Masterson, MD, Angela Shenkerman, APN, Angela K. Smith, Benadette Makori, Barton A. Kamen, MD, PhD

Blood (2004) 104 (11): 1950.

https://doi.org/10.1182/blood.V104.11.1950.1950

Published: 2004

NARROW

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Utilizing Medical Students As Patient Mentors: An Intervention to Improve Transition Readiness in Young Adults with Sickle Cell Disease

Changes in Serum TARC Predict PET Response Among Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma Treated with Brentuximab Vedotin and Gemcitabine: A Report from the Children's Oncology Group

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Novel Homozygous VHL Mutation in Exon 2 (413C>T:P138L) Is Associated with Congenital Polycythemia, Elevated Level of RUNX1/AML1 Transcript, but Not with the Cancer.

AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.

Phase IIB Trial of Aminopterin in Multiagent Therapy for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) at High Risk of Relapse.

Aminopterin Can Replace Methotrexate for Children with Newly Diagnosed Acute Lymphoblastic Leukemia without Excessive Toxicity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only